Bills Committee on Undesirable Medical Advertisements
(Amendment) (No.2) Bill 2004

Meeting on Thursday, 17 February 2005 at 4:45 pm
in the Chamber of the Legislative Council Building

Agenda

I.Meeting with deputations and the Administration
(4:45 pm - 6:25 pm)

LC Paper No. CB(2)853/04-05(01)
(attached)

-The Administration's response to issues raised by the Bills Committee at the meeting on 17 January 2005

LC Paper No. CB(2)846/04-05(01)
(issued on 14.2.2005)
(Chinese version only)

-Further submission from the Consumer Council

LC Paper No. CB(2)879/04-05(01)
(attached)
(Chinese version only)

-Submission from the Society for Community Organization

The Lion Rock Institute

The Assn. of Accredited Advertising Agents of Hong Kong

Easy Finder Limited

IN21/04-05
(attached)

-Supplementary information note on "Regulation of Health Food in the United States, the United Kingdom and the European Union" prepared by the Research and Library Services Division

(A list of other relevant papers previously issued is in the Appendix)

II.Any other business
(6:25 pm - 6:30 pm)

Council Business Division 2
Legislative Council Secretariat
17 February 2005

Appendix

Other relevant papers previously issued



Background information on the Bill

Ref : HWF CR 1/3231/03 Pt.8
(issued by the Health, Welfare and Food Bureau in October 2004)

-Legislative Council Brief

LC Paper No. LS3/04-05
(issued vide LC Paper No. CB(2)47/04-05 on 14.10.2004)

-Legal Service Division Report on the Bill

LC Paper No. CB(2)54/04-05(01)
(issued on 1.11.2004)

-Background paper prepared by Legislative Council Secretariat

IN18/04-05
(issued vide LC Paper No. CB(2)648/04-05 on 13.1.2005)

-Information note on "Recent developments in the regulation of health food in the United States" prepared by the Research and Library Services Division

IN19/04-05
(issued vide LC Paper No. CB(2)648/04-05 on 13.1.2005)

-Information note on "Regulation of health food in the United Kingdom" prepared by the Research and Library Services Division

The Bill and marked-up copy

LC Paper No. CB(3)35/04-05
(issued on 8.10.2004)

-The Bill

(issued vide LC Paper No. CB(2)251/04-05 on 19.11.2004)

-Marked-up copy of the Bill

Letter from Legal Service Division to the Administration

LC Paper No. CB(2)259/04-05(02)
(issued on 22.11.2004)

-Letter dated 27 October 2004 from the Legal Service Division to the Administration

LC Paper No. CB(2)673/04-05(01)
(issued on 14.1.2005)

-Letter dated 6 December 2004 from Legal Service Division to the Administration

Administration's response to Legal Service Division's letter

LC Paper No. CB(2)259/04-05(03)
(issued on 22.11.2004)

-Administration's response to Legal Service Division's letter dated 27 October 2004

Papers provided by the Administration

LC Paper No. CB(2)251/04-05(01)
(issued vide LC Paper No. CB(2)259/04-05 on 22.11.2004)

-The Administration's response to issues raised by the Bills Committee at the meeting on 2 November 2004

LC Paper No. CB(2)364/04-05(01)
(English version issued on 7.12.2004; Chinese version issued vide LC Paper No. CB(2)370/04-05 on 9.12.2004)

-The Administration's response to issues raised by the Bills Committee at the meeting on 23 November 2004

LC Paper No. CB(2)580/04-05(01)
(issued vide LC Paper No. CB(2)630/04-05 on 12.1.2005)

-The Administration's response to issues raised by the Bills Committee at the meeting on 9 December 2004

Submissions received

LC Paper No. CB(2)251/04-05(02)
(issued on 19.11.2004)
(Chinese version only)

-Submission from the Hong Kong Chinese Herbalists Association Ltd.

LC Paper No. CB(2)251/04-05(03)
(issued on 19.11.2004)
(Chinese version only)

-Submission from the Hong Kong Chinese Prepared Medicine Traders Association Ltd.

LC Paper No. CB(2)251/04-05(04)
(issued vide LC Paper No. CB(2)273/04-05 on 24.11.2004)

-Submission from the Hong Kong Health Food Association

LC Paper No. CB(2)251/04-05(05)
(issued on 19.11.2004))
(Chinese version only)

-Submission from the Modernized Chinese Medicine International Association

LC Paper No. CB(2)251/04-05(06)
(issued on 19.11.2004)
(Chinese version only)

-Submission from the Direct Selling of Hong Kong Ltd.

LC Paper No. CB(2)251/04-05(07)
(issued on 19.11.2004)
(Chinese version only)

-Submission from the Ocean Pharmaceutical (Hong Kong) Limited

LC Paper No. CB(2)251/04-05(08)
(issued vide LC Paper No. CB(2)273/04-05 on 24.11.2004)

-Submission from the Hong Kong Retail Management Association

LC Paper No. CB(2)251/04-05(09)
(English version issued on 19.11.2004; Chinese version issued vide LC Paper No. CB(2)259/04-05 on 22.11.2004)

-Submission from the Consumer Council

LC Paper No. CB(2)251/04-05(10)
(issued on 19.11.2004)
(Chinese version only)

-Submission from the Hong Kong Pharmaceutical Manufacturers Association Ltd.

LC Paper No. CB(2)251/04-05(11)
(issued on 19.11.2004)
(Chinese version only)

-Submission from the Hong Kong YEE YEE Tong Chinese Medicine Merchants Association Ltd.

LC Paper No. CB(2)251/04-05(12)
(issued vide LC Paper No. CB(2)259/04-05 on 22.11.2004)
(English version only)

-Submission from the Hong Kong Doctors Union

LC Paper No. CB(2)251/04-05(13)
(issued vide LC Paper No. CB(2)259/04-05 on 22.11.2004)
(English version only)

-Submission from the Society of Hospital Pharmacists of Hong Kong

LC Paper No. CB(2)251/04-05(14)
(issued vide LC Paper No. CB(2)273/04-05 on 24.11.2004)
(Chinese version only)

-Submission from the Chinese Manufacturers' Association of Hong Kong

LC Paper No. CB(2)251/04-05(15)
(issued vide LC Paper No. CB(2)259/04-05 on 22.11.2004)
(English version only)

-Submission from the Hong Kong Suppliers Association

LC Paper No. CB(2)251/04-05(16)
(issued on 19.11.2004)
(English version only)

-Submission from Mr Yip Ming

LC Paper No. CB(2)259/04-05(01)
(issued on 22.11.2004)
(English version only)

-Submission from the Hong Kong Medical Association

LC Paper No. CB(2)273/04-05(01)
(issued on 24.11.2004)
(Chinese version only)

-Submission from the Chinese Medicine Merchants Association Ltd.

LC Paper No. CB(2)273/04-05(02)
(issued on 24.11.2004)
(Chinese version only)

-Submission from the Hong Kong Society of Chinese Medicines

LC Paper No. CB(2)273/04-05(03)
(issued on 24.11.2004)
(Chinese version only)

-Submission from the International General Chinese Herbalists and Medicine Professionals Association Ltd.

LC Paper No. CB(2)301/04-05(01)
(issued on 30.11.2004)
(Chinese version only)

-Submission from the Hong Kong Medicine Dealers' Guild

LC Paper No. CB(2)301/04-05(02)
(issued on 30.11.2004)
(Chinese version only)

-Submission from Watson's The Chemist

LC Paper No. CB(2)364/04-05(02)
(issued on 7.12.2004)

-Submission from the Hong Kong Association of The Pharmaceutical Industry

LC Paper No. CB(2)374/04-05(01)
(issued on 8.12.2004)
(English version only)

-Submission from the A.S. Watson Group (HK) Limited - PARKnSHOP

LC Paper No. CB(2)434/04-05(01)
(issued on 15.12.2004)
(English version only)

-Submission from Professor S K LAM of the Faculty of Medicine of the University of Hong Kong

LC Paper No. CB(2)475/04-05(01)
(issued on 20.12.2004)
(English version only)

-Submission from the Hong Kong Academy of Medicine

LC Paper No. CB(2)580/04-05(02)
(issued on 7.1.2005)
(Chinese version only)

-Copy of letter dated 4 January 2005 from Hon LI Kwok-ying to the Administration

LC Paper No. CB(2)580/04-05(03)
(issued on 7.1.2005)
(Chinese version only)

-Submission from the Lion Rock Institute

LC Paper No. CB(2)630/04-05(01)
(issued on 12.1.2005)
(Chinese version only)

-Submission from the Better Hong Kong Movement Association

LC Paper No. CB(2)630/04-05(02)
(issued on 12.1.2005)
(Chinese version only)

-Submission from Mr Alexander YUEN